Vasopressor drugs for the prevention and treatment of hypotension during neuraxial anaesthesia for Caesarean delivery: a Bayesian network meta-analysis of fetal and maternal outcomes.

MLA

Singh, Preet M., et al. “Vasopressor Drugs for the Prevention and Treatment of Hypotension during Neuraxial Anaesthesia for Caesarean Delivery: A Bayesian Network Meta-Analysis of Fetal and Maternal Outcomes.” British Journal of Anaesthesia, vol. 124, no. 3, Mar. 2020, pp. e95–107. EBSCOhost, https://doi.org/10.1016/j.bja.2019.09.045.

APA

Singh, P. M., Singh, N. P., Reschke, M., Ngan Kee, W. D., Palanisamy, A., & Monks, D. T. (2020). Vasopressor drugs for the prevention and treatment of hypotension during neuraxial anaesthesia for Caesarean delivery: a Bayesian network meta-analysis of fetal and maternal outcomes. British Journal of Anaesthesia, 124(3), e95–e107. https://doi.org/10.1016/j.bja.2019.09.045

Chicago

Singh, Preet M, Narinder P Singh, Matthew Reschke, Warwick D Ngan Kee, Arvind Palanisamy, and David T Monks. 2020. “Vasopressor Drugs for the Prevention and Treatment of Hypotension during Neuraxial Anaesthesia for Caesarean Delivery: A Bayesian Network Meta-Analysis of Fetal and Maternal Outcomes.” British Journal of Anaesthesia 124 (3): e95–107. doi:10.1016/j.bja.2019.09.045.